Report cover image

Cell and Gene Therapy Tools and Reagents: Global Markets

Publisher BCC Research
Published Feb 05, 2026
Length 175 Pages
SKU # WA20868314

Description

Report Scope

The report provides an overview of the global market for cell and gene therapy tools and reagents. It includes global revenue ($ millions) for the base year 2024, estimated data for 2025, and forecast data from 2026 through 2030. In this report, the market is segmented based on product type, application and end user. By product type, the market is segmented into vectors, GMP proteins, GMP antibodies, GMP small molecules, bioreactors, multiplex immunoassays, immunoassays, leukapheresis, cell separation, cell expansion, cytokine release syndrome (CRS) monitoring, cryopreservation and media.

The application segment covered cancer, rare diseases and other diseases. By end user, the market is divided into pharmaceutical and biotechnology companies, academic research institutes, and clinical laboratories.

The regions covered in this study are North America, Europe, Asia-Pacific and rest of the World (RoW) (which includes the Middle East and Africa and South America), with analysis of the markets in the U.S., Canada, Mexico, Germany, the U.K., Italy, France, Spain, the rest of Europe, China, Japan, India, South Korea and the rest of Asia-Pacific. The report covers the trends and challenges that affect the market. It includes an analysis of the competitive landscape, with the ranking of leading companies and their market shares. The report also has a dedicated section of company profiles that covers details of leading companies. It analyzes companies’ environmental, social and corporate governance (ESG) initiatives.

Report Includes
  • 77 data tables and 55 additional tables
  • An overview of the global market for cell and gene therapy tools and reagents
  • In-depth analysis of global market trends, featuring historical revenue data for 2022-2025. This analysis includes projections of compound annual growth rates (CAGRs) through 2030
  • Evaluation of the current market size and revenue growth prospects specific to the cell and gene therapy tools and reagents market, accompanied by a market share analysis by type, application, end user, and region
  • Analysis of current and future demand in the cell and gene therapy tools and reagents market, along with a detailed analysis of the competitive environment, market regulations and reimbursement practices
  • Discussion of the prevalence of infectious disease, metabolic disorders and chronic ailments, along with the recent technological advances, competitive landscape, and the industry value chain
  • Analysis of drivers, challenges, and opportunities affecting market growth
  • Coverage of evolving technologies, the current and future market potential, R&D activities, growth strategies, new product pipeline, regulatory framework and reimbursement scenarios, and ESG trends of the market
  • Market share analysis of the key market participants in the industry, along with their research priorities, product portfolios, global rankings and company competitive landscape
  • Profiles of major companies within the industry, including Thermo Fisher Scientific Inc., Cytiva (Danaher Corp.), Merck KGaA, Miltenyi Biotec, and Sartorius AG


Companies Mentioned

Abcam Ltd.
Adverum Biotechnologies Inc.
Akron Biotech
Bio-rad Laboratories Inc.
Bio-techne
Cytiva
Fujifilm Irvine Scientific (Fujifilm Biosciences)
Merck Kgaa
Miltenyi Biotec
Proteintech Group Inc.
Qiagen
Revvity
Sartorius Ag
Stemcell Technologies
Thermo Fisher Scientific Inc.

Table of Contents

175 Pages
Chapter 1 Executive Summary
Market Outlook
Scope Of Report
Market Summary
Overview
Current Market Scenario
Segmental Analysis
Regional Market Insights
Emerging Technologies
Conclusion
Chapter 2 Market Overview
Cell And Gene Therapy Overview
Cell Therapy
Gene Therapy
Types Of Cell And Gene Therapy
Gene Therapy
Cell Therapy
Common Equipment Used
Approved Cell And Gene Therapy Products
Macroeconomic Factors Analysis
Demographic Factors
Geopolitical Factors
Impact Of U.S. Tariffs
Porter's Five Forces Analysis
Chapter 3 Market Dynamics
Market Dynamics
Market Drivers
Increasing Investments In Cgt Research
Expanding Clinical And Commercial Cgt Products
Rising Demand For Precision Medicine
Capacity Expansions For Clinical And Commercial Manufacturing
Growing Number Of Strategic Initiatives
Rising Aging Population And The Increasing Prevalence Of Chronic Diseases
Market Restraints/Challenges
Complex Manufacturing And Supply Chain
High Cost Of Development
Lack Of Skilled Workforce
Regulatory Hurdles
Market Opportunities
Rising Demand For Cgts In Emerging Countries
Growing Demand For Off-the-shelf Products
Chapter 4 Regulatory Landscape
Overview
U.S.
Cell Therapy Regulations
Gene Therapy Regulations
Viral And Non-viral Vectors
Media
Gmp Proteins And Antibodies
Leukapheresis
Europe
Asia-pacific
Chapter 5 Emerging Technologies And Developments
Key Takeaways
Closed And Automated Systems
Single-use Technologies And Miniaturization
Chapter 6 Market Segmentation Analysis
Segmentation Breakdown
Market Analysis By Product Type
Key Takeaways
Immunoassays
Bioreactors
Leukapheresis
Gmp Antibodies
Multiplex Immunoassays
Vectors
Cell Separation
Cryopreservation
Cell Expansion
Media
Gmp Proteins
Gmp Small Molecules
Crs Monitoring
Market Analysis By Application
Key Takeaways
Cancer
Rare Diseases
Other Diseases
Market Analysis By End User
Key Takeaways
Pharmaceutical And Biotechnology Companies
Academic And Research Institutes
Clinical Laboratories
Geographic Breakdown
Market Analysis By Region
Key Takeaways
North America
Europe
Asia-pacific
Rest Of The World
Chapter 7 Competitive Intelligence
Key Takeaways
Competitive Analysis
Strategic Initiatives
Agreements, Collaborations And Partnerships
Acquisitions
Investments And Expansions
Chapter 8 Sustainability In Global Market For Cell And Gene Therapy Tools And Reagents: An Esg Perspective
Introduction To Esg
Sustainability Trends And Company Initiatives
Environmental Factors
Social Factors
Governance Factors
Social And Governance Initiatives
Concluding Remarks
Chapter 9 Appendix
Research Methodology
Sources
Abbreviations
Company Profiles
Abcam Ltd.
Adverum Biotechnologies Inc.
Akron Biotech
Bio-rad Laboratories Inc.
Bio-techne
Cytiva
Fujifilm Irvine Scientific (Fujifilm Biosciences)
Merck Kgaa
Miltenyi Biotec
Proteintech Group Inc.
Qiagen
Revvity
Sartorius Ag
Stemcell Technologies
Thermo Fisher Scientific Inc.
Emerging Startups/Market Disruptors

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us